glycine propionyl-l-carnitine acetyl-l-carnitine GPLC - Propionyl L Carnitine, Glycine, L Carnitine Propionyl L-Carnitine with Glycine Heart

Y.MartinJ

Jacobs PL, Goldstein ER, Blackburn W, Orem I, Hughes JJ: Glycine propionyl-L-carnitine produces enhanced anaerobic work capacity with reduced lactate accumulation in resistance trained males

10.1073/pnas.1316569111 Summary Keywords trimethylamine N-oxide, chronic kidney disease, gut microbiota, targeted TMAO drugs, mechanism, treatment Citation Zixin Y, Lulu C, Xiangchang Z, Qing F, Binjie Z, Chunyang L, Tai R and Dongsheng O (2022) TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review

Giving L-carnitine intravenously (by IV) can prevent severe liver toxicity in people who accidentally ingested or took too much valproic acid